Skip to main content

Table 1 Baseline characteristics of patients before and after propensity score matching

From: Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data

No. of patients

Before match

After match

IBS (n = 365)

Controls (n = 1157)

p

IBS (n = 354)

Controls (n = 354)

p

Age (median [IQR])†

45 [33, 59]

45 [35, 57]

0.407

45 [36, 57]

46 [35, 59]

0.610

BMI (median [IQR])†

23.67 [21.46, 25.80]

22.80 [20.94, 5.62]

0.027*

22.90 [20.97, 25.65]

23.03 [20.98, 25.48]

0.605

Country (n, %)

  

 < 0.001*

  

1.000

 USA

175 (47.95)

832 (71.91)

 

175 (49.44)

175 (49.44)

 

 UK

169 (46.30)

274 (23.68)

 

160 (45.20)

160 (45.20)

 

 Australia

11 (3.01)

19 (1.64)

 

9 (2.54)

9 (2.54)

 

 Switzerland

6 (1.64)

12 (1.04)

 

6 (1.69)

6 (1.69)

 

 Canada

4 (1.10)

20 (1.73)

 

4 (1.13)

4 (1.13)

 

Sex (n, %)

  

 < 0.001*

  

1.000

 Female

238 (65.21)

488 (42.18)

 

227 (64.12)

227 (64.12)

 

 Male

127 (34.79)

669 (57.82)

 

127 (35.88)

127 (35.88)

 
  1. IBS irritable bowel syndrome, BMI body weight index
  2. †p value was derived from the Mann–Whitney test in data of continuous variables with abnormal distribution (M, Median; IQR, Interquartile Range). p value was derived from the Chi-square test or fisher’s exact test in data of categorical variables from IBS and healthy controls (n,%). *p < 0.05